Intended for healthcare professionals


NICE proposes faster process to appraise cheaper drugs

BMJ 2016; 355 doi: (Published 18 October 2016) Cite this as: BMJ 2016;355:i5592
  1. Susan Mayor
  1. London

The National Institute for Health and Care Excellence (NICE) has announced proposals for a “fast track” appraisal process for drugs and other health technologies that offer “exceptional” value for money, together with clearer guidance on automatic NHS funding for any treatments it approves for very rare conditions.1

The proposals, which are part of a joint consultation by NICE and NHS England, would mean that treatments likely to have a cost per quality adjusted life year (QALY) of less than £10 000 (€11 065; $12 160) would be assessed using a …

View Full Text

Log in

Log in through your institution


* For online subscription